Mental Health IssueNCT06185959
Evaluating a New Mental Health Group for Asians and Asian Americans
An observational study of Mental Health Issue, run by Stanford University at 1 site in United States.
Trial summary
This study's overarching aim is to evaluate a new psychoeducation and process group for Asian and Asian American psychiatric outpatients. This is a 12 week mental health group which will focus on both educational content related to Asian mental health as well as increasing connection between group members. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Mental Health Issue
- What is being tested?
- Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 30 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jun 2024to 1 Jun 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Age range is 18 years and older. All genders are eligible. For ethnic background, to be eligible for this study, participants must identify as Asian or Asian American due to the group under investigation being specifically designed as an Asian and Asian American Psychoeducation and Process Group. The research study will be offered to all patients enrolling in the Asian and Asian American Psychoeducation and Process Group in the Stanford Department of Psychiatry \& Behavioral Sciences. The purpose of this study is to evaluate patient experiences in this psychoeducation and process group, so participants will be limited to those enrolling in the group as part of their clinical treatment.
Who may be able to join
- 18 years and older
- Participants must identify as Asian or Asian American
- Sufficient English proficiency to participate in a psychotherapy group conducted in English
Who cannot join
- Unable to provide written informed consent
- Elevated suicide risk (e.g. recent active suicidal ideation, past-year suicide attempt) without a current individual mental health provider
- Any other challenges that would preclude participation in group psychotherapy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Stanford University - Department of Psychiatry and Behavioral Sciences
Palo Alto, California, 94304
Lisa Zhang, Ph.D., 650-721-8590, lisaz@stanford.edu
About this study
Official title: Examining the Feasibility and Impact of a Novel Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
This study's overarching aim is to evaluate a new psychoeducation and process group for Asian and Asian American psychiatric outpatients. This is a 12 week mental health group which will focus on both educational content related to Asian mental health as well as increasing connection between group members. We hypothesize that participants in the group will experience a decrease in psychiatric symptoms at the conclusion of the group compared to their symptoms at the beginning of group. We also hypothesize that participants will feel more socially connected after the group.
- Conditions
- Mental Health Issue
- Being tested
- Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Psychoeducation and Process Group for Asian and Asian American Psychiatric OutpatientsBehavioural
Participants will be individuals enrolling in a 1.5 hour weekly therapy group lasting 12 weeks and will be invited to participate in research on group processes and outcomes. The psychoeducation and process group will be a 12-session weekly closed group with 10-15 participants per group (2-3 groups total) conducted via Zoom to enhance accessibility and reduce barriers to care. Groups will be co-led by licensed clinical psychologists with experience providing both group psychotherapy and culturally responsive services. Group sessions will include brief check-ins, collaborative agenda-setting, a mini-didactic, individual reflection, and group discussion. The didactics curriculum will include topics such as intergenerational trauma, cultural differences in emotional expression, the model minority myth, family dynamics, racism, and positive connections to culture.
| Study group | Role | What they receive |
|---|---|---|
| Patients in a Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients | Not described Receives: Behavioral: Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient Health Questionnaire-9 (PHQ-9)
Depression symptoms assessed on 4-point Likert scale. Score range from 0 to 27, with higher scores representing more severe depression symptoms
Measured: Once at baseline, once at 6 weeks, once at 12 weeks
Generalized Anxiety Disorder Screener-7 (GAD-7)
Anxiety symptoms assessed on 4-point Likert scale. Score range from 0 to 21, with higher scores representing more severe anxiety symptoms
Measured: Once at baseline, once at 6 weeks, once at 12 weeks
Secondary outcomes (3)
Social Connectedness Scale
Subjective social connectedness assessed on 6-point Likert scale. Score range from 20 to 120, with higher scores representing higher perceived social connectedness
Measured: Once at baseline, once at 12 weeks
Rosenberg Self-Esteem Scale
Subjective self-esteem assessed on 4-point Likert scale. Score range from 10 to 40, with higher scores representing higher self-esteem
Measured: Once at baseline, once at 12 weeks
Self-Stigma of Seeking Help Scale
Help-seeking self-stigma assessed on 5-point Likert scale. Score range from 10 to 50, with higher scores representing higher self-stigma of seeking help
Measured: Once at baseline, once at 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Dec 2023
- Study start1 Jun 2024
- Primary completion1 Jun 2027 (estimated)
- Study completion1 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental Health IssueStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Lisa Zhang, Stanford University
- Investigators
- Lisa Zhang, PhD, Principal investigator, Stanford UniversityMelanie Hom, PhD, Principal investigator, Stanford UniversityStacy Lin, PhD, Principal investigator, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06185959
- Sponsor's protocol ID
- 72936
- Status last verified
- May 2025
- First submitted
- 15 Dec 2023
- Last updated
- 25 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining the Feasibility and Impact of a Novel Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
- ClinicalTrials.gov ID
- NCT06185959
- Acronym / sponsor ID
- 72936
- Conditions
- Mental Health Issue
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Study start
- 1 Jun 2024 (actual)
- Primary completion
- 1 Jun 2027 (estimated)
- Study completion
- 1 Jun 2027 (estimated)
- First posted
- 29 Dec 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study's overarching aim is to evaluate a new psychoeducation and process group for Asian and Asian American psychiatric outpatients. This is a 12 week mental health group which will focus on both educational content related to Asian mental health as well as increasing connection between group members. We hypothesize that participants in the group will experience a decrease in psychiatric symptoms at the conclusion of the group compared to their symptoms at the beginning of group. We also hypothesize that participants will feel more socially connected after the group.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients in a Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients | – | Behavioral: Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Age range is 18 years and older. All genders are eligible. For ethnic background, to be eligible for this study, participants must identify as Asian or Asian American due to the group under investigation being specifically designed as an Asian and Asian American Psychoeducation and Process Group. The research study will be offered to all patients enrolling in the Asian and Asian American Psychoeducation and Process Group in the Stanford Department of Psychiatry \& Behavioral Sciences. The purpose of this study is to evaluate patient experiences in this psychoeducation and process group, so participants will be limited to those enrolling in the group as part of their clinical treatment.
Key inclusion criteria (3 listed)
- 18 years and older
- Participants must identify as Asian or Asian American
- Sufficient English proficiency to participate in a psychotherapy group conducted in English
Key exclusion criteria (3 listed)
- Unable to provide written informed consent
- Elevated suicide risk (e.g. recent active suicidal ideation, past-year suicide attempt) without a current individual mental health provider
- Any other challenges that would preclude participation in group psychotherapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Psychoeducation and Process Group for Asian and Asian American Psychiatric OutpatientsParticipants will be individuals enrolling in a 1.5 hour weekly therapy group lasting 12 weeks and will be invited to participate in research on group processes and outcomes. The psychoeducation and process group will be a 12-session weekly closed group with 10-15 participants per group (2-3 groups total) conducted via Zoom to enhance accessibility and reduce barriers to care. Groups will be co-led by licensed clinical psychologists with experience providing both group psychotherapy and culturally responsive services. Group sessions will include brief check-ins, collaborative agenda-setting, a mini-didactic, individual reflection, and group discussion. The didactics curriculum will include topics such as intergenerational trauma, cultural differences in emotional expression, the model minority myth, family dynamics, racism, and positive connections to culture. | Behavioural | Patients in a Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients |
Primary outcome
Patient Health Questionnaire-9 (PHQ-9)
Time frame: Once at baseline, once at 6 weeks, once at 12 weeks
Depression symptoms assessed on 4-point Likert scale. Score range from 0 to 27, with higher scores representing more severe depression symptoms
Generalized Anxiety Disorder Screener-7 (GAD-7)
Time frame: Once at baseline, once at 6 weeks, once at 12 weeks
Anxiety symptoms assessed on 4-point Likert scale. Score range from 0 to 21, with higher scores representing more severe anxiety symptoms
3 secondary outcomes
Social Connectedness Scale
Time frame: Once at baseline, once at 12 weeks
Rosenberg Self-Esteem Scale
Time frame: Once at baseline, once at 12 weeks
Self-Stigma of Seeking Help Scale
Time frame: Once at baseline, once at 12 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2025.
- Individual participant dataSharing planned: No
Related trials for Mental Health Issue
Active, not recruiting
Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers
Mental Health Issue, Mental Health Disorder
Active, not recruiting
Digital Therapeutics for Behavior Problems
Problem Behavior, Child Behavior
Recruiting
VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia
Lewy Bodies Disease, Depression Disorder
Active, not recruiting
Tailoring CPP for the Foster Care Setting
Behavior Problem
Active, not recruiting
Supporting Health in Veterans With Heart Failure
Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Lisa Zhang, PhD principal investigator
Stanford University
Melanie Hom, PhD principal investigator
Stanford University
Stacy Lin, PhD principal investigator
Stanford University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Mental Health Issue, run by Stanford University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 25 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Lisa Zhang, PhD (650-721-8590, lisaz@stanford.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient Health Questionnaire-9 (PHQ-9) (time frame: Once at baseline, once at 6 weeks, once at 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2025.